YOLFTbeta
Laseroptek Co., Ltd.

Laseroptek Co., Ltd.

199550 · KQ · Healthcare / Medical Devices

2,820.00KRW-125.00 (-4.24%)

Price History

Full chart

Market Stats

Previous Close2,945.00
Open2,905.00
Day Range2,810.00 – 3,055.00
52-Week Range1,900.00 – 7,700.00
Volume17.76K
Market Cap47.87B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.26
50-Day Avg2,913.20
200-Day Avg4,497.51

About

Laseroptek Co., Ltd. develops and manufactures aesthetic and medical laser devices in South Korea. Its laser devices perform aesthetic and medical dermatological treatments for a range of indications, such as benign pigmentation lesions, fine lines and wrinkles, scar revision, skin rejuvenation and lifting, hair removal, vascular lesions, vitiligo, psoriasis, atopic dermatitis, leukoderma, and alopecia areata. The company was founded in 2000 and is based in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Chang-Jin Lee
  • Employees81
  • Headquarters#203&204 Hyundai I Valley, Seongnam-si, South Korea, Korea
  • Websitehttps://www.laseroptek.com

Leadership

  • Mr. Chang-Jin LeeCEO, President & Director · b. 1968
  • Won-Sul KimQuality Certification Team Leader · b. 1969
  • Dr. Hong ChuFounder & Chairman
  • Ui-yong LeeDirector & Accounting Manager
  • Joo-yeon LeeHead of Marketing & MD · b. 1972
  • Seok-ju SongManaging Director

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.65B30.05B34.35B33.04B25.70B
Growth (%)-+61.11%+14.32%-3.83%-22.22%
Cost of Revenue10.56B16.90B18.68B18.51B15.83B
Gross Profit8.09B13.14B15.68B14.53B9.87B
Gross Margin43.39%43.74%45.63%43.99%38.40%
Operating Expense7.44B10.61B10.81B14.73B21.91B
Operating Income649.16M2.54B4.86B-195.21M-12.04B
Operating Margin3.48%8.45%14.16%-0.59%-46.88%
EBITDA-3.88B1.63B2.00B-10.19B
EBITDA Margin-12.92%4.75%6.07%-39.66%
Net Income-1.26B2.82B16.78M-783.25M-10.74B
Net Income Margin-6.78%9.37%0.05%-2.37%-41.81%
R&D848.42M891.46M974.87M1.12B1.31B
R&D as % of Total Revenue4.55%2.97%2.84%3.39%5.12%
Interest Expense1.39B1.19B406.77M711.28M537.46M
Interest Expense % of Total Revenue7.48%3.95%1.18%2.15%2.09%

Balance Sheet

Currency: KRW2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets19.50B19.67B25.19B29.81B45.35B36.55B
Total Liabilities22.40B23.61B13.13B9.73B14.89B14.37B
Total Equity-2.90B-3.94B12.06B20.08B30.46B22.18B
Cash162.00K938.00K510.00K356.70M6.11B5.52B
Net Debt-1.44B1.48B3.97B-1.31B

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-633.83M1.44B-196.15M-3.34B-6.39B
Investing Cash Flow--1.28B-3.05B6.88B-
Financing Cash Flow--1.20B126.81M2.21B-
Capital Expenditure1.34B926.93M271.48M1.21B714.87M
Free Cash Flow-1.97B508.81M-467.63M-4.55B-7.11B
FCF to OCF310.72%35.44%238.41%136.37%111.18%

Earnings

Report DateMar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------
EPS Actual-213.14158.92-34.8517.89-210.97-231.38-198.61-191.09-96.09-52.04
Surprise----------
Timing----------

Key Statistics & Ratios

Market Cap47.87B
Enterprise Value42.49B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.51
Price / Book1.61
Revenue (TTM)31.68B
Gross Profit (TTM)12.38B
EBITDA-8.73B
Profit Margin-22.50%
Operating Margin-11.27%
Return on Equity-24.74%
Return on Assets-14.83%
Shares Outstanding14.84M
Shares Float9.35M
Beta-0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 10, 20261152:1067